81 results on '"McCluggage, W Glenn"'
Search Results
2. FIGO 2023 endometrial cancer staging system: recommendations for the UK
3. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii
4. Teratoma‐associated and so‐called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features
5. Pan‐TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls
6. Mesonephric‐like adenocarcinoma of the female genital tract: novel observations and detailed molecular characterisation of mixed tumours and mesonephric‐like carcinosarcomas
7. Rare and unusual tumours associated with characteristic molecular events: the importance of specialist pathology review
8. A Subset of SMARCB1 (INI‐1)‐deficient vulvar neoplasms express germ cell markers
9. Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression
10. Ovarian microcystic stromal tumour: from morphological observations to syndromic associations
11. Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020)
12. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach
13. Tubo‐ovarian high‐grade serous carcinomas commonly express CA19.9
14. Progress in the pathological arena of gynecological cancers
15. p53 immunohistochemical analysis of fusion‐positive uterine sarcomas
16. Uterine plexiform tumourlets: multifocal and solitary cases with subsets expressing melanocytic markers
17. DICER1‐associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing
18. β‐catenin signatures in the fallopian tube: an emerging concept
19. NTRKand other recently described kinase fusion positive uterine sarcomas: A review of a group of rare neoplasms
20. Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series
21. SWI/SNF protein and claudin‐4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum
22. Somatic tumour testing establishes that bilateral DICER1 ‐associated ovarian Sertoli–Leydig cell tumours represent independent primary neoplasms
23. Macroscopy under the microscope: a critical reappraisal of grossing techniques
24. Endometriosis‐related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions
25. Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results
26. Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer
27. High EMSY expression defines a BRCA‐like subgroup of high‐grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum
28. Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa
29. GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangement
30. Expanding the morphological spectrum of ovarian microcystic stromal tumour
31. DICER1 hot-spot mutations in ovarian gynandroblastoma
32. Primary fallopian tube sex cord tumour: tubal counterpart of uterine tumour resembling ovarian sex cord tumour
33. Towards developing a meaningful grading system for cervical squamous cell carcinoma
34. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells
35. IdenticalTP 53mutations provide evidence that late‐recurring tubo‐ovarian high‐grade serous carcinomas do not represent new peritoneal primaries
36. Uterine tumour resembling ovarian sex cord tumour: first report of a large series with follow-up
37. High-grade serous carcinoma of tubo-ovarian origin: recent developments
38. Molecular subtyping of mammary-like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas
39. Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm
40. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology
41. Recently characterized molecular events in uncommon gynaecological neoplasms and their clinical importance
42. Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours
43. CD34 expression in undifferentiated endometrial carcinoma
44. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics
45. Differential expression of E-cadherin and catenins in ovarian sex cord stromal tumours
46. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas
47. p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma
48. Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non‐neoplastic remnants?
49. Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a E uropean multinational epidemiological study
50. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.